Stocks and Investing Stocks and Investing
Tue, May 24, 2022
Mon, May 23, 2022

David Risinger Initiated (ABBV) at Sell and Held Target at $140 on, May 23rd, 2022


Published on 2024-10-27 21:15:04 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of SVB Leerink, Initiated "AbbVie Inc." (ABBV) at Sell and Held Target at $140 on, May 23rd, 2022.

David has made no other calls on ABBV in the last 4 months.



There are 14 other peers that have a rating on ABBV. Out of the 14 peers that are also analyzing ABBV, 5 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Luisa Hector of "Berenberg" Maintained at Hold with Increased Target to $135 on, Friday, May 20th, 2022
  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $156 on, Friday, April 22nd, 2022
  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $174 on, Tuesday, April 12th, 2022
  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $140 on, Tuesday, April 12th, 2022
  • Colin Bristow of "UBS" Downgraded from Strong Buy to Hold and Increased Target to $147 on, Monday, February 28th, 2022


These are the ratings of the 9 analyists that currently disagree with David


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $188 on, Monday, May 2nd, 2022
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $200 on, Monday, May 2nd, 2022
  • Tim Anderson of "Wolfe Research" Maintained at Buy with Decreased Target to $170 on, Sunday, May 1st, 2022
  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $160 on, Friday, April 29th, 2022
  • Gary Nachman of "BMO Capital" Maintained at Buy with Increased Target to $174 on, Monday, April 25th, 2022
  • Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $180 on, Thursday, April 14th, 2022
  • Terence Flynn of "Morgan Stanley" Maintained at Buy with Increased Target to $192 on, Wednesday, April 6th, 2022
  • Andrew Baum of "Citigroup" Reiterated at Strong Buy with Increased Target to $170 on, Tuesday, March 1st, 2022
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $166 on, Friday, February 4th, 2022
Contributing Sources